| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 815 |
| 1 | METHOTREXATE SODIUM | 692 |
| 2 | METHOTREXATE | 597 |
| 3 | ADALIMUMAB | 537 |
| 4 | TOCILIZUMAB | 466 |
| 5 | LEFLUNOMIDE | 428 |
| 6 | SULFASALAZINE | 413 |
| 7 | PREDNISONE | 403 |
| 8 | ABATACEPT | 399 |
| 9 | INFLIXIMAB | 382 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIAMCINOLONE HEXACETONIDE | 45 | 0.1718 |
| 1 | TETANUS IMMUNE GLOBULIN (HUMAN) | 7 | 0.0642 |
| 2 | PAROMOMYCIN SULFATE | 4 | 0.0377 |
| 3 | GOLIMUMAB | 229 | 0.0182 |
| 4 | GOLD | 92 | 0.0158 |
| 5 | CORTISONE ACETATE | 196 | 0.0157 |
| 6 | ANAKINRA | 256 | 0.0151 |
| 7 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 8 | 0.0122 |
| 8 | CALCIUM GLUCONATE | 144 | 0.0118 |
| 9 | DESOXIMETASONE | 209 | 0.0108 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 951 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 589 |
| 2 | Corticosteroid [EPC] | 522 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 499 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 473 |
| 5 | Antirheumatic Agent [EPC] | 428 |
| 6 | Aminosalicylate [EPC] | 415 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 399 |
| 8 | Vitamin B12 [EPC] | 375 |
| 9 | Vitamin C [EPC] | 373 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 256 | 0.0151 |
| 1 | Interleukin-5 Antagonist [EPC] | 9 | 0.0131 |
| 2 | Endoglycosidase [EPC] | 16 | 0.0086 |
| 3 | Human Immunoglobulin G [EPC] | 158 | 0.0075 |
| 4 | Interleukin-17A Antagonist [EPC] | 219 | 0.0059 |
| 5 | Aminosalicylate [EPC] | 415 | 0.0041 |
| 6 | Antirheumatic Agent [EPC] | 428 | 0.0040 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 473 | 0.0034 |
| 8 | Provitamin D2 Compound [EPC] | 93 | 0.0031 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 399 | 0.0029 |